Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the move
05:31am, Monday, 03'rd Jul 2023
Tesla stock TSLA, +1.66% soared 6% in premarket trade after the electric vehicle maker reported a record number of deliveries in the second quarter.
AstraZeneca sees £7bn wiped from its value as lung cancer results fall short of 'best-case scenario'
04:19am, Monday, 03'rd Jul 2023
Shares in pharmaceutical giant AstraZeneca PLC (LSE:AZN) fell 4.4% in early trading, erasing £7.3bn from the company's market value. The drop comes amid investor concerns over the results of a high-p
AstraZeneca reports positive results in late-stage trial of lung cancer therapy
04:12am, Monday, 03'rd Jul 2023
British drugmaker AstraZeneca said on Monday its anti-body drug for lung cancer had met two of its main goals in a late-stage trial.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Wednesday, 28'th Jun 2023
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
AstraZeneca to spend $400 mln to plant 200 mln trees, cut carbon footprint
03:12am, Wednesday, 28'th Jun 2023
British drugmaker AstraZeneca on Wednesday announced it would invest $400 million to plant over 200 million trees by 2030 as part of its strategy for reducing carbon emissions in line with the Paris A
Is AstraZeneca a Top Stock to Buy Right Now?
02:00pm, Thursday, 22'nd Jun 2023
Dividend-paying pharma stocks frequently deliver market-beating returns on capital. AstraZeneca stock, for instance, has consistently trounced the broader markets over the past 10 years.
AstraZeneca (AZN) May Reportedly Spin-Off its Chinese Business
01:16pm, Tuesday, 20'th Jun 2023
AstraZeneca (AZN) reportedly plans to spin-off its China business and list it separately in Hong Kong to protect itself from rising tensions between the United States and China.
AstraZeneca may soon spin off its business in China
10:36am, Monday, 19'th Jun 2023
AstraZeneca plc (LON: AZN) is considering spinning off its business in China, the Financial Times reported on Monday. Listing in Shanghai or Hong Kong also possible The pharmaceutical behemoth could r
AstraZeneca reportedly mulling China spin-off
04:12am, Monday, 19'th Jun 2023
AstraZeneca PLC (LSE:AZN), the UK's largest listed company, is considering carving out its China business and listing it separately in Hong Kong, as a potential shield against escalating geopolitical
2 Best Biotech Stocks to Buy Right Now
10:07am, Friday, 16'th Jun 2023
These European pharma giants have long-established records of success. AstraZeneca has 12 medicines that are on track to become blockbusters.
AstraZeneca (AZN) Breast Cancer Combo Drug Gets Priority Review
11:18am, Tuesday, 13'th Jun 2023
The FDA grants priority review status to AstraZeneca's (AZN) capivasertib/Faslodex combination for the treatment of adult patients with HR-positive, HER2-negative locally advanced breast cancer.
AstraZeneca turns to cows to cut U.S. carbon footprint
07:05am, Tuesday, 13'th Jun 2023
Drugmaker AstraZeneca is switching to biogas produced from cow manure and food waste in the United States, it said on Tuesday, in a deal to cut its carbon emissions there.
AstraZeneca (AZN) & Quell to Co-Develop Autoimmune Cell Therapies
10:58am, Monday, 12'th Jun 2023
AstraZeneca (AZN) enters into a collaboration agreement with Quell Therapeutics to co-develop novel cell therapy options in major autoimmune indications for an upfront payment of $85 million.
FDA Panel Endorses AstraZeneca (AZN), Sanofi's RSV Antibody
02:58pm, Friday, 09'th Jun 2023
The FDA's AMDAC unanimously recommends AstraZeneca (AZN)/Sanofi's (SNY) nirsevimab as full immunization against RSV disease for all infants.
AstraZeneca signs $2 bln agreement with Quell to develop cell therapies
04:03am, Friday, 09'th Jun 2023
AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.
